Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

655 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Epigenetic alteration and microRNA dysregulation in cancer.
Suzuki H, Maruyama R, Yamamoto E, Kai M. Suzuki H, et al. Among authors: maruyama r. Front Genet. 2013 Dec 3;4:258. doi: 10.3389/fgene.2013.00258. Front Genet. 2013. PMID: 24348513 Free PMC article. Review.
Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines.
Terasawa K, Toyota M, Sagae S, Ogi K, Suzuki H, Sonoda T, Akino K, Maruyama R, Nishikawa N, Imai K, Shinomura Y, Saito T, Tokino T. Terasawa K, et al. Among authors: maruyama r. Br J Cancer. 2006 Mar 27;94(6):914-21. doi: 10.1038/sj.bjc.6602984. Br J Cancer. 2006. PMID: 16479257 Free PMC article.
Identification of DFNA5 as a target of epigenetic inactivation in gastric cancer.
Akino K, Toyota M, Suzuki H, Imai T, Maruyama R, Kusano M, Nishikawa N, Watanabe Y, Sasaki Y, Abe T, Yamamoto E, Tarasawa I, Sonoda T, Mori M, Imai K, Shinomura Y, Tokino T. Akino K, et al. Among authors: maruyama r. Cancer Sci. 2007 Jan;98(1):88-95. doi: 10.1111/j.1349-7006.2006.00351.x. Cancer Sci. 2007. PMID: 17083569 Free article.
PRDM5 identified as a target of epigenetic silencing in colorectal and gastric cancer.
Watanabe Y, Toyota M, Kondo Y, Suzuki H, Imai T, Ohe-Toyota M, Maruyama R, Nojima M, Sasaki Y, Sekido Y, Hiratsuka H, Shinomura Y, Imai K, Itoh F, Tokino T. Watanabe Y, et al. Among authors: maruyama r. Clin Cancer Res. 2007 Aug 15;13(16):4786-94. doi: 10.1158/1078-0432.CCR-07-0305. Clin Cancer Res. 2007. PMID: 17699856
Gene amplification and overexpression of PRDM14 in breast cancers.
Nishikawa N, Toyota M, Suzuki H, Honma T, Fujikane T, Ohmura T, Nishidate T, Ohe-Toyota M, Maruyama R, Sonoda T, Sasaki Y, Urano T, Imai K, Hirata K, Tokino T. Nishikawa N, et al. Among authors: maruyama r. Cancer Res. 2007 Oct 15;67(20):9649-57. doi: 10.1158/0008-5472.CAN-06-4111. Cancer Res. 2007. PMID: 17942894
Epigenetic inactivation of RASSF2 in oral squamous cell carcinoma.
Imai T, Toyota M, Suzuki H, Akino K, Ogi K, Sogabe Y, Kashima L, Maruyama R, Nojima M, Mita H, Sasaki Y, Itoh F, Imai K, Shinomura Y, Hiratsuka H, Tokino T. Imai T, et al. Among authors: maruyama r. Cancer Sci. 2008 May;99(5):958-66. doi: 10.1111/j.1349-7006.2008.00769.x. Epub 2008 Feb 24. Cancer Sci. 2008. PMID: 18294275 Free article.
Cytoplasmic RASSF2A is a proapoptotic mediator whose expression is epigenetically silenced in gastric cancer.
Maruyama R, Akino K, Toyota M, Suzuki H, Imai T, Ohe-Toyota M, Yamamoto E, Nojima M, Fujikane T, Sasaki Y, Yamashita T, Watanabe Y, Hiratsuka H, Hirata K, Itoh F, Imai K, Shinomura Y, Tokino T. Maruyama R, et al. Carcinogenesis. 2008 Jul;29(7):1312-8. doi: 10.1093/carcin/bgn060. Epub 2008 Feb 29. Carcinogenesis. 2008. PMID: 18310659 Free PMC article.
Frequent epigenetic inactivation of SFRP genes in hepatocellular carcinoma.
Takagi H, Sasaki S, Suzuki H, Toyota M, Maruyama R, Nojima M, Yamamoto H, Omata M, Tokino T, Imai K, Shinomura Y. Takagi H, et al. Among authors: maruyama r. J Gastroenterol. 2008;43(5):378-89. doi: 10.1007/s00535-008-2170-0. Epub 2008 Jul 1. J Gastroenterol. 2008. PMID: 18592156
655 results